Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03685578 · ClinicalTrials.gov registry record
CERENOVUS Neurothrombectomy Devices Registry
A clinical trial, sponsored by Cerenovus, Part of DePuy Synthes Products.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT03685578 is a clinical trial that has completed, run by Cerenovus, Part of DePuy Synthes Products. The registered enrollment target is 2,000 participants.
The verdict
NCT03685578 has completed, sponsored by Cerenovus, Part of DePuy Synthes Products.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
A post-market registry evaluating the EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC™ Aspiration Catheter, and CEREGLIDE 71 Intermediate Catheter in acute ischemic stroke patients with confirmed intracranial vessel occlusion.
Interventions
- DEVICE EmboTrap® Revascularization Device
- DEVICE CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter
- DEVICE CEREGLIDE 71 Intermediate Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2025-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03685578
The ClinicalTrials.gov registry entry for NCT03685578 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerenovus, Part of DePuy Synthes Products, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which EmboTrap® Revascularization Device is the first listed.
NCT03685578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03685578 about?
NCT03685578 is a clinical study titled "CERENOVUS Neurothrombectomy Devices Registry". A post-market registry evaluating the EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC™ Aspiration Catheter, and CEREGLIDE 71 Intermediate Catheter in acute ischemic stroke patients with confirmed intracranial vessel occlusion.
What is the current status of trial NCT03685578?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2018-09-28. Estimated completion is 2025-02-20.
What interventions are being tested in trial NCT03685578?
The interventions under investigation include: EmboTrap® Revascularization Device (DEVICE), CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter (DEVICE), CEREGLIDE 71 Intermediate Catheter (DEVICE).
Who is sponsoring clinical trial NCT03685578?
This trial is sponsored by Cerenovus, Part of DePuy Synthes Products, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.